{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/OKYO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T04:07:59.035Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11316,"canonical_name":"OKYO Pharma Ltd","cik":"0001849296","uei":null,"lei":null,"duns":null,"ticker":"OKYO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":37},"count":37,"timeline":[{"ts":"2026-10-06","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-10-06","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-045836","accession_number":"0001493152-26-045836","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-09-29","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-044760","accession_number":"0001493152-26-044760","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-09-09","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-041864","accession_number":"0001493152-26-041864","importance":30},{"ts":"2026-09-08","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-09-08","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-041686","accession_number":"0001493152-26-041686","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"20-F/A","title":"20-F/A — OKYO Pharma Ltd — 2026-08-07","url_slug":"/sec/cik-0001849296/20-f-a/0001493152-26-036599","accession_number":"0001493152-26-036599","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4/A","title":"4/A — OKYO Pharma Ltd — 2026-08-07","url_slug":"/sec/cik-0001849296/4-a/0001493152-26-036580","accession_number":"0001493152-26-036580","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4/A","title":"4/A — OKYO Pharma Ltd — 2026-08-07","url_slug":"/sec/cik-0001849296/4-a/0001493152-26-036581","accession_number":"0001493152-26-036581","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4/A","title":"4/A — OKYO Pharma Ltd — 2026-08-07","url_slug":"/sec/cik-0001849296/4-a/0001493152-26-036584","accession_number":"0001493152-26-036584","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — OKYO Pharma Ltd — 2026-07-29","url_slug":"/sec/cik-0001849296/3/0001493152-26-035203","accession_number":"0001493152-26-035203","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — OKYO Pharma Ltd — 2026-07-29","url_slug":"/sec/cik-0001849296/4/0001493152-26-035212","accession_number":"0001493152-26-035212","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-28","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034927","accession_number":"0001493152-26-034927","importance":30},{"ts":"2026-07-27","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-27","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034686","accession_number":"0001493152-26-034686","importance":30},{"ts":"2026-07-27","kind":"sec.insider.a","reporter":"Patil Rajkumar V.","title":"Chief Scientific Officer","shares":3363,"price_per_share":1.49,"usd_value":5011,"security_title":"COMMON STOCK","importance":15.00501087},{"ts":"2026-07-23","kind":"sec.filing","form_type":"4","title":"4 — OKYO Pharma Ltd — 2026-07-23","url_slug":"/sec/cik-0001849296/4/0001493152-26-034409","accession_number":"0001493152-26-034409","importance":30},{"ts":"2026-07-23","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-23","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034316","accession_number":"0001493152-26-034316","importance":30},{"ts":"2026-07-23","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-23","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034362","accession_number":"0001493152-26-034362","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"4","title":"4 — OKYO Pharma Ltd — 2026-07-22","url_slug":"/sec/cik-0001849296/4/0001493152-26-034236","accession_number":"0001493152-26-034236","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-22","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034160","accession_number":"0001493152-26-034160","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-22","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034197","accession_number":"0001493152-26-034197","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-22","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034201","accession_number":"0001493152-26-034201","importance":30},{"ts":"2026-07-22","kind":"sec.insider.a","reporter":"Dempsey Robert John","title":"CHIEF EXECUTIVE OFFICER","shares":15000,"price_per_share":1.539,"usd_value":23085,"security_title":"COMMON STOCK","importance":15.023085},{"ts":"2026-07-21","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-21","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-033991","accession_number":"0001493152-26-033991","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-21","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-034019","accession_number":"0001493152-26-034019","importance":30},{"ts":"2026-07-21","kind":"sec.insider.a","reporter":"CERRONE GABRIELE M","title":"","shares":22500,"price_per_share":1.45,"usd_value":32625,"security_title":"COMMON STOCK","importance":15.032625},{"ts":"2026-07-21","kind":"sec.insider.a","reporter":"Mantelli Flavio","title":"CHIEF MEDICAL OFFICER","shares":20000,"price_per_share":1.4,"usd_value":28000,"security_title":"COMMON STOCK","importance":15.028},{"ts":"2026-07-21","kind":"sec.insider.a","reporter":"BRANCACCIO JOHN P","title":"","shares":5000,"price_per_share":1.477,"usd_value":7385,"security_title":"COMMON STOCK","importance":15.007385},{"ts":"2026-07-21","kind":"sec.insider.a","reporter":"JACOB GARY S","title":"CHIEF DEVELOPMENT OFFICER","shares":3500,"price_per_share":1.4,"usd_value":4900,"security_title":"COMMON STOCK","importance":15.0049},{"ts":"2026-07-20","kind":"sec.filing","form_type":"20-F","title":"20-F — OKYO Pharma Ltd — 2026-07-20","url_slug":"/sec/cik-0001849296/20-f/0001493152-26-033847","accession_number":"0001493152-26-033847","importance":30},{"ts":"2026-07-20","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-20","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-033850","accession_number":"0001493152-26-033850","importance":30},{"ts":"2026-07-20","kind":"sec.insider.a","reporter":"CERRONE GABRIELE M","title":"","shares":25000,"price_per_share":1.4,"usd_value":35000,"security_title":"COMMON STOCK","importance":15.035},{"ts":"2026-07-08","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-08","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-032407","accession_number":"0001493152-26-032407","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-07-07","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-032253","accession_number":"0001493152-26-032253","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"3","title":"3 — OKYO Pharma Ltd — 2026-06-17","url_slug":"/sec/cik-0001849296/3/0001493152-26-029084","accession_number":"0001493152-26-029084","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — OKYO Pharma Ltd — 2026-06-10","url_slug":"/sec/cik-0001849296/4/0001493152-26-028131","accession_number":"0001493152-26-028131","importance":30},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"CERRONE GABRIELE M","title":"","shares":300000,"price_per_share":1.72,"usd_value":516000,"security_title":"COMMON STOCK","importance":15.516},{"ts":"2026-05-19","kind":"sec.filing","form_type":"6-K","title":"6-K — OKYO Pharma Ltd — 2026-05-19","url_slug":"/sec/cik-0001849296/6-k/0001493152-26-024343","accession_number":"0001493152-26-024343","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — OKYO Pharma Ltd — 2026-05-15","url_slug":"/sec/cik-0001849296/schedule-13g/0000919574-26-003208","accession_number":"0000919574-26-003208","importance":55}]}